162 related articles for article (PubMed ID: 38009297)
1. GPNMB
Meng Y; Zhao Q; Sang Y; Liao J; Ye F; Qu S; Nie P; An L; Zhang W; Jiao S; Huang A; Zhou Z; Wei L
EMBO J; 2023 Dec; 42(24):e114060. PubMed ID: 38009297
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.
Dong ZR; Cai JB; Shi GM; Yang YF; Huang XY; Zhang C; Dong RZ; Wei CY; Li T; Ke AW; Fan J
Cancer Lett; 2023 Jun; 564():216186. PubMed ID: 37105392
[TBL] [Abstract][Full Text] [Related]
3. Tumor endothelial cell-induced CD8
Sakano Y; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takahashi H; Asaoka T; Tanemura M; Wada H; Doki Y; Eguchi H
Cancer Sci; 2022 May; 113(5):1625-1638. PubMed ID: 35289033
[TBL] [Abstract][Full Text] [Related]
4. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
[TBL] [Abstract][Full Text] [Related]
7. GPNMB: a potent inducer of immunosuppression in cancer.
Lazaratos AM; Annis MG; Siegel PM
Oncogene; 2022 Oct; 41(41):4573-4590. PubMed ID: 36050467
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
Kowalik MA; Puliga E; Cabras L; Sulas P; Petrelli A; Perra A; Ledda-Columbano GM; Morandi A; Merlin S; Orrù C; Sanchez-Martin C; Fornari F; Gramantieri L; Parri M; Rasola A; Bellomo SE; Sebastian C; Follenzi A; Giordano S; Columbano A
J Hepatol; 2020 Jun; 72(6):1159-1169. PubMed ID: 31954205
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of glycoprotein nonmetastatic B by colony-stimulating factor-1 and epithelial cell adhesion molecule in hepatocellular carcinoma cells.
Tian F; Liu C; Wu Q; Qu K; Wang R; Wei J; Meng F; Liu S; Chang H
Oncol Res; 2013; 20(8):341-50. PubMed ID: 23924854
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
11. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
[TBL] [Abstract][Full Text] [Related]
15. Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma.
Marongiu F; Serra MP; Sini M; Angius F; Laconi E
Aging (Albany NY); 2014 Jan; 6(1):26-34. PubMed ID: 24464501
[TBL] [Abstract][Full Text] [Related]
16. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
17. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
Khosla R; Rastogi A; Ramakrishna G; Pamecha V; Mukhopadhyay A; Vasudevan M; Sarin SK; Trehanpati N
Stem Cells Transl Med; 2017 Mar; 6(3):807-818. PubMed ID: 28176469
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
19. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
20. Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis.
Tan HY; Wang N; Zhang C; Chan YT; Yuen MF; Feng Y
Hepatology; 2021 Jun; 73(6):2326-2341. PubMed ID: 33068461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
